Evidence map›Paper›PMID 35371447›Full record

ArticleClinical kidney journal2022

Changing trends in presentation and indications of biopsy in lupus nephritis: data from the Spanish Registry of Glomerulonephritis.

Amir Shabaka, Eugenia Landaluce-Triska, José Emilio Sánchez-Álvarez, Gema Fernández-Juárez

Open access · goldAbstract read
In one paragraph

Article in Clinical kidney journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Late-onset lupus nephritis: what is the evidence?Kidney research and clinical practice · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Amir ShabakaNephrology Department, Hospital Universitario Fundación Alcorcón, Madrid, Spain.ORCID https://orcid.org/0000-0001-7039-4701
Eugenia Landaluce-TriskaNephrology Department, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
José Emilio Sánchez-ÁlvarezNephrology Department, Hospital Universitario de Cabueñes, Gijón, Spain.ORCID https://orcid.org/0000-0002-4431-3223
Gema Fernández-JuárezNephrology Department, Hospital Universitario Fundación Alcorcón, Madrid, Spain.ORCID https://orcid.org/0000-0001-6641-7763
Hospital Universitario Fundación Alcorcón · ESHospital Universitario De Cabueñes · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: With the ageing population and changes in the indications of diagnostic and protocol biopsies in systemic lupus erythematosus in recent years, an impact on the incidence and presentation of lupus nephritis (LN) is expected. The aim of this study was to analyse the epidemiological changes regarding clinical and histological presentation of LN in kidney biopsies performed from 1994 to 2019 included in the Spanish Registry of Glomerulonephritis. Methods: We analysed data from 28 791 kidney biopsies from 130 Spanish hospitals comparing demographic, clinical and histological data. We divided the cohort according to the age of onset of LN into pediatric onset (<18 years), adult onset (18-50 years) and late onset (>50 years). Results: The incidence of LN has decreased from 9.6% of all kidney biopsies in the period 1994-2013 to 7% in the last quarter of the observation period (2014-2019) (P < 0.001), despite an increase in the proportion of patients with LN that underwent repeat biopsies (16.6-24%; P < 0.001). The age of onset of LN has increased from 32 ± 14 to 38 ± 14 years (P < 0.001), with an increase in the proportion of late-onset LN (from 13% to 22% of incident LN; P < 0.001). There were no differences in the distribution of histological features at presentation over the study period. Patients with late-onset LN showed fewer gender differences, had lower GFR and presented with less-proliferative forms of LN compared with early-onset LN. Conclusions: The frequency of biopsy-proven LN has been decreasing in recent years, despite an increasing number of repeat biopsies. Late-onset LN is increasing, presenting with worse kidney function but fewer proliferative lesions compared with younger-onset LN.

Indexed as

ageepidemiologyglomerulonephritislate-onset lupus nephritissystemic lupus erythematosus

Identifiers

PMID35371447
PMCPMC8967535
OpenAlexW3216067485

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.